Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 103
of 6Next
1:

P-cadherin expression in breast cancer: a review.

Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC.

Breast Cancer Res. 2007;9(5):214. Review.

PMID: 18001487 [PubMed - indexed for MEDLINE]

2:

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC.

Clin Cancer Res. 2005 Aug 15;11(16):5869-77.

PMID: 16115928 [PubMed - indexed for MEDLINE]

3:

Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.

Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2005 May-Jun;25(3A):1615-22.

PMID: 16033070 [PubMed - indexed for MEDLINE]

4:

Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.

Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C.

Am J Pathol. 1995 Mar;146(3):605-12.

PMID: 7534041 [PubMed - indexed for MEDLINE]

5:

[Immunohistochemical study of P-cadherin in breast cancer]

Kovács A, Walker RA, Nagy A, Gomba S, Jones L, Dearing S.

Orv Hetil. 2002 Feb 24;143(8):405-9. Hungarian.

PMID: 11921707 [PubMed - indexed for MEDLINE]

6:

The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.

Yoshida R, Kimura N, Harada Y, Ohuchi N.

Int J Oncol. 2001 Mar;18(3):513-20.

PMID: 11179480 [PubMed - indexed for MEDLINE]

7:

Persistent E-cadherin expression in inflammatory breast cancer.

Kleer CG, van Golen KL, Braun T, Merajver SD.

Mod Pathol. 2001 May;14(5):458-64.

PMID: 11353057 [PubMed - indexed for MEDLINE]

8:

The role of cadherin-mediated adhesion in breast cancer.

Sommers CL.

J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):219-29. Review.

PMID: 10887495 [PubMed - indexed for MEDLINE]

9:

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.

Berx G, Van Roy F.

Breast Cancer Res. 2001;3(5):289-93. Epub 2001 Jun 28. Review.

PMID: 11597316 [PubMed - indexed for MEDLINE]

10:

Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.

Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B.

Cancer. 2005 Apr 15;103(8):1631-43.

PMID: 15742334 [PubMed - indexed for MEDLINE]

11:

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO.

Histopathology. 2005 Jun;46(6):685-93.

PMID: 15910600 [PubMed - indexed for MEDLINE]

12:

In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.

Batistatou A, Peschos D, Tsanou H, Charalabopoulos A, Nakanishi Y, Hirohashi S, Agnantis NJ, Charalabopoulos K.

Br J Cancer. 2007 May 7;96(9):1404-8. Epub 2007 Apr 17.

PMID: 17437014 [PubMed - indexed for MEDLINE]

13:

Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.

Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA.

J Cell Biol. 2000 Feb 21;148(4):779-90. Erratum in: J Cell Biol 2000 Apr 3;149(1):following 236.

PMID: 10684258 [PubMed - indexed for MEDLINE]

14:

N-cadherin promotes adhesion between invasive breast cancer cells and the stroma.

Hazan RB, Kang L, Whooley BP, Borgen PI.

Cell Adhes Commun. 1997 Mar;4(6):399-411.

PMID: 9177902 [PubMed - indexed for MEDLINE]

15:

Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer?

Paredes J, Milanezi F, Reis-Filho JS, Leitão D, Athanazio D, Schmitt F.

Pathol Res Pract. 2002;198(12):795-801.

PMID: 12608656 [PubMed - indexed for MEDLINE]

16:

Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.

Pinho SS, Matos AJ, Lopes C, Marcos NT, Carvalheira J, Reis CA, Gärtner F.

BMC Cancer. 2007 Jul 6;7:124.

PMID: 17617904 [PubMed - indexed for MEDLINE]

17:

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas.

Kovács A, Dhillon J, Walker RA.

Mol Pathol. 2003 Dec;56(6):318-22.

PMID: 14645693 [PubMed - indexed for MEDLINE]

18:

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.

Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO.

J Pathol. 1999 Apr;187(5):523-9.

PMID: 10398116 [PubMed - indexed for MEDLINE]

19:

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.

Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR.

BMC Cancer. 2006 Mar 2;6:48.

PMID: 16512896 [PubMed - indexed for MEDLINE]

20:

High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.

Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO.

Int J Cancer. 2005 May 1;114(5):720-9.

PMID: 15609312 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 103
of 6Next